Ingevity (NGVT) EPS (Weighted Average and Diluted) (2016 - 2025)
Ingevity (NGVT) has disclosed EPS (Weighted Average and Diluted) for 11 consecutive years, with -$1.88 as the latest value for Q4 2025.
- Quarterly EPS (Weighted Average and Diluted) rose 76.41% to -$1.88 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.16 through Dec 2025, up 74.03% year-over-year, with the annual reading at -$4.15 for FY2025, 64.98% up from the prior year.
- EPS (Weighted Average and Diluted) for Q4 2025 was -$1.88 at Ingevity, down from $1.18 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $1.98 in Q3 2022, with the low at -$7.97 in Q4 2024.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.44, with a median of $0.72 recorded in 2021.
- The sharpest move saw EPS (Weighted Average and Diluted) skyrocketed 1900.0% in 2022, then tumbled 5213.33% in 2024.
- Over 5 years, EPS (Weighted Average and Diluted) stood at $0.74 in 2021, then tumbled by 40.54% to $0.44 in 2022, then tumbled by 134.09% to -$0.15 in 2023, then crashed by 5213.33% to -$7.97 in 2024, then skyrocketed by 76.41% to -$1.88 in 2025.
- According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$1.88, $1.18, and -$4.02 for Q4 2025, Q3 2025, and Q2 2025 respectively.